Institutions · Entity Annotation Prototype (beta)

2articles mentioning institutions

2institution mentions

1distinct institutions extracted

0%of mentions human-reviewed

Active filtersEntity: Columbia University Institutional Review Board ×

Columbia University Institutional Review Board

This institution is selected. Its supporting articles are shown below.

Columbia University Institutional Review Board2

Articles mentioning Columbia University Institutional Review Board

2 articles · page 1 of 1

516 An open-label, phase II multicenter study of rituximab or tocilizumab for steroid-dependent or steroid-refractory immune-related adverse events due to immune checkpoint inhibitors

jitc · abstract · 2025-11-04 · 1 matching annotations

91.0%

Memorial Sloan Kettering Cancer Center Institutional Review Board Columbia University Institutional Review Board rituximab tocilizumab bullous pemphigoid prednisone arthritis osteoporosis

…view Board (IRB # AAAS9173). The study was also approved by the Memorial Sloan Kettering Cancer Center Institutional Review Board (IRB protocol number: 21-519).Abstract 516 Figure 1Tocilizumab …

Pragmatic, multicentre, factorial, randomised controlled trial of sepsis electronic prompting for timely intervention and care (SEPTIC trial): a protocol

bmjopen · abstract · 2025-08-11 · 1 matching annotations

75.4%

Columbia University Institutional Review Board sepsis SEPTIC SEPTIC-IP

….Ethics and dissemination Ethics approval was obtained from the Columbia University Institutional Review Board (IRB) serving as a single IRB. Results will be disseminated in …